Press releases

Total demand of approximately €11.8 million, i.e. an oversubscription rate of 128% of the offer Full exercise of the extension clause...

DEINOVE (Alternext Paris: ALDEI) announces its 2015 interim results. 19% reduction in interim net loss thanks to good control of operating...

DEINOVE has reached the third and penultimate milestone of its DEINOL project. This milestone validates the work of DEINOVE's proprietary...

A key patent granted in the United States ensures a broader perspective 4 industrial and scientific partnerships with structural impact...

DEINOVE has improved substantially the laboratory production of isoprenoids In accordance with the support agreement signed with the ADEME...

DEINOVE (Alternext Paris: ALDEI), a cleantech company that designs and develops new industrial production processes based on the...

DEINOVE has set up with KEPLER CHEUVREUX a guaranteed equity line funding in four tranches over three years, with a maximum amount of € 15...

Having demonstrated the value of DEINOL technology on model substrates (glucose/xylose), DEINOVE is now proceeding to test the technology...

October 2nd & 3rd, 2014 - Paris, Palais Brongniart, France Montpellier, October 1st, 2014 - Deinove (Alternext Paris: ALDEI), a...

DEINOVE (Alternext Paris: ALDEI) and SOFIPROTÉOL report signing a three-year collaboration agreement to develop a production process for...